FDA Changes Strategy on mRNA COVID-19 Jab

The FDA proposed on Monday that the mRNA COVID-19 jab be given annually like the influenza shot.

JUST IN: The FDA proposed on Monday that the mRNA COVID-19 jab be given annually like the flu shot.

— DailyNoah.com (@DailyNoahNews) January 23, 2023

The strategy change is an indicator that the U.S. federal government has conceded that COVID-19 is here to stay.

COVID-19 is a similar pathogen to the flu and will become endemic.

We have to deal with it!

The ‘conspiracy theorists’ and outlets who reported the truth have said this for quite a while.

COVID-19 will never go away and should be treated like the flu.

However, the experimental injections belong in the trash.

They’ve caused nothing but harm to people around the world.

Now, the only difference is the approach taken by public health agencies.

Their narrative of getting every individual injected with an experimental drug is falling apart.

Too much damage is noticeable to the masses and government officials are attempting to cover their tracks.

“I think we created this unrealistic expectation that this vaccine can protect against mild disease. That’s not true,” said FDA Vaccine Advisory Committee Member Dr. Paul Offit.

“But it was marketed and it was pushed to everyone. Why?” a FOX 5 host asked Dr. Offit.

“I don’t agree with that,” Offit responded.

“The CDC’s own data…shows really only certain groups benefit in terms of protection against severe disease,” he explained.

“So I’m not sure why the CDC pushed forward with this.”

WATCH:

🚨 NEW — FDA Vaccine Advisory Committee Member Dr. Paul Offit Walks Back the CDC’s ‘Needle in Every Arm’ Narrative

“The CDC’s own data…shows really only certain groups benefit in terms of protection against severe disease.

So I’m not sure why the CDC pushed forward with this.” pic.twitter.com/LMeImfP22X

— Chief Nerd (@TheChiefNerd) January 23, 2023

It certainly sounds like the blame game between the FDA and CDC.

They’re both complicit in attempting to push needles into every arm.

Rep. Thomas Massie asked if there was any “FDA approved, properly labeled, COVID ‘vaccine’ in the United States yet?”

Has anyone seen an FDA approved, properly labeled, COVID “vaccine” in the United States yet?

If so, please post a picture of the label and post the name and location of the provider. Thank you.

— Thomas Massie (@RepThomasMassie) January 23, 2023

That’s a good question.

Can the FDA provide this?

Not that their approval means anything, but it exemplifies their lack of transparency to the American public.

The COVID-19 injection catastrophe has caused many Americans to lose all trust in the FDA.

I got Covid shots in 2021, because I believed the claimed clinical trial results, and trusted the FDA.

But looking at mountains of evidence since, I no longer think I made the right decision. These shots are much more dangerous and much less effective than claimed.

— Dr. Eli David (@DrEliDavid) January 18, 2023

The side effects of the vaccine were always on FDA site. We were warning about it from day one. The press and the government misled the people. The vax insert was empty. People didn’t have informed consent. Btw Covid19 has always been treatable. Sinister https://t.co/7Qwb09x8ZK. pic.twitter.com/0pxBJHj0os

— Dr. Stella Immanuel MD (@stella_immanuel) January 22, 2023

FDA wants to mandate COVID boosters on an annual basis. Best evidence is that more boosters cause autoimmune system collapse, greater susceptibility to a variety of infections, and myocarditis. FDA is trying to kill more people faster.https://t.co/CShOYcwDK8

— Jim Rickards (@JamesGRickards) January 23, 2023

Although multiple esteemed cardiologists have called for the suspension of the mRNA COVID-19 jabs, the FDA will appease Big Pharma.

Pfizer and Moderna will continue raking in profits with annual COVID-19 shots.

Nevertheless, the COVID-19 shots are here to stay unless there is enough public refusal to take them.

The Wall Street Journal explained:

Most people would get one Covid-19 shot annually—as they do with the flu shot—under Food and Drug Administration proposals for simplifying the nation’s Covid-19 vaccine procedures.

The drug regulator also proposed that people getting vaccinated for the first time receive vaccines that target both Omicron and the original strain of the coronavirus.

The proposals, outlined in materials the FDA released Monday, would mark the biggest changes to Covid-19 vaccinations since boosters rolled out and are a sign of the nation’s shift to a more endemic-like approach to the coronavirus.

Vaccine experts who advise the FDA are scheduled to meet Thursday to discuss the proposals. The advisers are scheduled to vote on whether to give the bivalent shot as the initial inoculation, as is already allowed in Europe.

This approach shouldn’t surprise anyone who has paid attention to the COVID-19 jab manufacturers the past two years.

The Pfizer and Moderna CEOs told the public to expect annual inoculations.

Albert Bourla, Pfizer CEO, said “the most likely scenario” is annual COVID-19 shots.

CNBC reported in 2021:

Bourla’s prediction about when normal life will resume is in keeping with that of ModernaCEO Stéphane Bancel. “As of today, in a year, I assume,” Bancel told the Swiss newspaper Neue Zuercher Zeitung, according to Reuters on Thursday, when asked for his estimate of a return to normal life.

In order to make that happen, Pfizer’s Bourla suggested it is likely annual coronavirus vaccine shots will be needed.

“The most likely scenario for me is that, because the virus is spread all over the world, that it will continue seeing new variants that are coming out,” Bourla said. “Also we will have vaccines that they will last at least a year, and I think the most likely scenario is annual vaccination, but we don’t know really, we need to wait and see the data.”

And don’t expect future COVID-19 shots to undergo any clinical trials.

Cont. from The Wall Street Journal:

The annual plan would make Covid-19 vaccinations more like annual flu shots. Advisers would meet every June to select the Covid-19 shot best able to match strains they expect to circulate in the fall, similar to how influenza vaccines are chosen.

The vaccines wouldn’t undergo rigorous clinical trials before being selected, just as influenza vaccines don’t. People could get the Covid-19 shots starting in September.

If a new and very dangerous Covid-19 variant appeared, the FDA could still call for an emergency, one-off vaccine—outside the annual schedule—to meet the new threat, agency staff said.